BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 1405725)

  • 21. IDH2 somatic mutations in chronic myeloid leukemia patients in blast crisis.
    Soverini S; Score J; Iacobucci I; Poerio A; Lonetti A; Gnani A; Colarossi S; Ferrari A; Castagnetti F; Rosti G; Cervantes F; Hochhaus A; Delledonne M; Ferrarini A; Sazzini M; Luiselli D; Baccarani M; Cross NC; Martinelli G
    Leukemia; 2011 Jan; 25(1):178-81. PubMed ID: 20962862
    [No Abstract]   [Full Text] [Related]  

  • 22. Rearrangement of the BCR/ABL and TCR-beta genes in lymph node blast crisis diagnosed of chronic myeloid leukemia.
    Villegas A; González FA
    Am J Hematol; 1994 Apr; 45(4):347. PubMed ID: 8178807
    [No Abstract]   [Full Text] [Related]  

  • 23. Author's reply to "Rearrangement of the BCR/ABL and TCR-beta genes in lymph node blast crisis diagnosed of chronic myeloid leukemia".
    van der Jagt R; Drouin J; Giulivi A; Huebsch LB; Tittley P
    Am J Hematol; 1994 Jul; 46(3):248. PubMed ID: 8192157
    [No Abstract]   [Full Text] [Related]  

  • 24. Lymphoid blast crisis in a patient with Philadelphia-chromosome-negative chronic myelocytic leukemia.
    Takahira H; Shibata K; Hirata J; Umemura T; Nishimura J; Nawata H
    Acta Haematol; 1989; 81(3):155-9. PubMed ID: 2496564
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Karyotypic changes during the course of blastic crisis of chronic myelogenous leukemia.
    Mitani K; Miyazono K; Urabe A; Takaku F
    Cancer Genet Cytogenet; 1989 Jun; 39(2):299-300. PubMed ID: 2752380
    [No Abstract]   [Full Text] [Related]  

  • 26. Frequent p53 gene mutations in blast crisis of chronic myelogenous leukemia, especially in myeloid crisis harboring loss of a chromosome 17p.
    Nakai H; Misawa S; Toguchida J; Yandell DW; Ishizaki K
    Cancer Res; 1992 Dec; 52(23):6588-93. PubMed ID: 1423304
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Simultaneous presence of major secondary chromosomal abnormalities in blast crisis of chronic myeloid leukemia.
    Lu CM; Wang E; Lawrence HJ
    Cancer Genet Cytogenet; 2007 Jan; 172(2):174-5. PubMed ID: 17213030
    [No Abstract]   [Full Text] [Related]  

  • 28. Ras oncogene mutations are rare late stage events in chronic myelogenous leukemia.
    LeMaistre A; Lee MS; Talpaz M; Kantarjian HM; Freireich EJ; Deisseroth AB; Trujillo JM; Stass SA
    Blood; 1989 Mar; 73(4):889-91. PubMed ID: 2645949
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clonal succession and deletion of bcr/abl sequences in chronic myelogenous leukemia with recurrent lymphoid blast crisis.
    Laneuville P; Sullivan AK
    Leukemia; 1991 Sep; 5(9):752-6. PubMed ID: 1943228
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Near haploid blast phase in a chronic myeloid leukemia detected by fluorescence in situ hybridization using a BCR-ABL probe.
    Gancberg D; Dargent JL; Verhest A; Kentos A; Feremans W; Lohrisch C; Kornreich A
    Cancer Genet Cytogenet; 2001 Jul; 128(2):172-4. PubMed ID: 11478300
    [No Abstract]   [Full Text] [Related]  

  • 31. GATA1 mutational analysis in chronic myeloid leukaemia.
    Halsey C; Fisher C; Strathdee G; Gibson B; Holyoake T; Vyas P; Graham G
    Br J Haematol; 2007 May; 137(4):375-6. PubMed ID: 17408401
    [No Abstract]   [Full Text] [Related]  

  • 32. Double P53 point mutation in extramedullary blast crisis of chronic myelogenous leukemia.
    Marasca R; Longo G; Luppi M; Barozzi P; Torelli G
    Leuk Lymphoma; 1994 Dec; 16(1-2):171-5. PubMed ID: 7696924
    [TBL] [Abstract][Full Text] [Related]  

  • 33. New variant translocation (8;20)(q22;q13) in bone marrow cells of extramedullary blast crisis in chronic myelogenous leukemia.
    Harada Y; Ishi K; Shirota T; Hayashi T
    Cancer Genet Cytogenet; 2000 Mar; 117(2):167-8. PubMed ID: 10704692
    [No Abstract]   [Full Text] [Related]  

  • 34. Different methylation patterns of the M-BCR gene in myeloblastic and lymphoblastic crisis of chronic myelocytic leukemia.
    Ge X; Tanaka K; Kamada N
    Chin Med J (Engl); 1996 Apr; 109(4):300-3. PubMed ID: 8758292
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Activation of Ha-ras in human chronic granulocytic and chronic myelomonocytic leukaemia.
    Gow J; Hughes D; Farr C; Hamblin T; Oscier D; Brown R; Padua RA
    Leuk Res; 1988; 12(10):805-10. PubMed ID: 3059070
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Validation and refinement of a RUNX1 mutation-associated gene expression signature in blast crisis chronic myeloid leukemia.
    Lee KL; Ko TK; Saw NYL; Javed A; Hillmer AM; Chuah C; Krishnan V; Ong ST
    Leukemia; 2022 Mar; 36(3):892-896. PubMed ID: 35121847
    [No Abstract]   [Full Text] [Related]  

  • 37. Genetic heterogeneity in blast crisis of chronic myelocytic leukemia.
    Ikeda T; Kita K; Miwa H; Kawakami K; Anazawa H; Ohno T; Nosaka T; Hatanaka M; Honjo T; Shirakawa S
    Leuk Res; 1990; 14(2):195-201. PubMed ID: 2156114
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association of a chromosomal 9,12 translocation with B cell precursor lymphoblastic blast crisis of a Ph+ chronic myelogenous leukaemia.
    Solary E; Mugneret F; Guy H; Caillot D; Carli PM; Turc-Carel C
    Br J Haematol; 1989 May; 72(1):106-8. PubMed ID: 2786730
    [No Abstract]   [Full Text] [Related]  

  • 39. CEBPA mutation in a case of chronic myeloid leukemia presenting in myeloid blast crisis.
    Yin Y; Li J; Yan W; Cheng Z; Sun N; Zhang G
    Leuk Lymphoma; 2017 Mar; 58(3):708-710. PubMed ID: 27379703
    [No Abstract]   [Full Text] [Related]  

  • 40. A study on the incidence of ABL gene deletion on derivative chromosome 9 in chronic myelogenous leukemia by interphase fluorescence in situ hybridization and its association with disease progression.
    Lee DS; Lee YS; Yun YS; Kim YR; Jeong SS; Lee YK; She CJ; Yoon SS; Shin HR; Kim Y; Cho HI
    Genes Chromosomes Cancer; 2003 Jul; 37(3):291-9. PubMed ID: 12759927
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.